Correlations between psoriasis and inflammatory bowel diseases

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Skroza, Nevena ^a   Proietti, Ilaria ^a   Pampena, Riccardo ^a   La Viola, Giorgio ^a   Bernardini, Nicoletta ^a   Nicolucci, Francesca ^a   Tolino, Ersilia ^a   Zuber, Sara ^a   Soccodato, Valentina ^a   Potenza, Concetta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E2; STAT4 PROTEIN; SYNAPSIN I; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CHROMOSOME 16Q; CHROMOSOME 1P; CHROMOSOME 5Q; CHROMOSOME 6P; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DIZYGOTIC TWINS; ENTERITIS; FIRST DEGREE RELATIVE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC HETEROGENEITY; HETEROZYGOSITY; HUMAN; HYPER IGE SYNDROME; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MISSENSE MUTATION; MYCOBACTERIUM BOVIS; PATHOGENESIS; PREVALENCE; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; BIOLOGICAL MODEL; COMORBIDITY; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INTESTINE; PATHOPHYSIOLOGY; RISK FACTOR; SKIN; STATISTICS; INFLAMMATORY BOWEL DISEASE;

COMORBIDITY; CYTOKINES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MODELS, BIOLOGICAL; PREVALENCE; PSORIASIS; RISK FACTORS; SKIN; STATISTICS AS TOPIC;

EID: 84881493457     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/983902     Document Type: Review

References (71)

1. Rudikoff D., Baral J., Lebwohl M., Psoriasis and Crohn's disease. The Mount Sinai Journal of Medicine 1999 66 article 206 2-s2.0-0033124322
2. Hoffmann R., Schieferstein G., Schunter F., Jenss H., Re: increased occurrence of psoriasis in patients with Crohn's disease and their relatives. The American Journal of Gastroenterology 1991 86 6 787 788 2-s2.0-0025728880
3. Potenza C., Annetta A., Bernardini N., Ciccone V., Grossi B., La Viola G., Nicolucci F., Proietti I., Skroza N., Tolino E., della Rocca C., di Cristofano C., Plaque Psoriasis: Anatomical, Clinical and Immunohistochemical Correlations During Anti-Tnfa Treatment 2010 1 Viareggio, Italy J. Medical Books edizioni Srl
4. Hammer B., Ashurst P., Naish J., Diseases associated with ulcerative colitis and Crohn's disease. Gut 1968 9 1 17 21 2-s2.0-0014252016
5. Yamamoto T., Yokoyama A., Coexistence of psoriasis vulgaris, ulcerative colitis, and thyroid adenoma. Journal of Dermatology 1997 24 4 275 276 2-s2.0-0030944630 (Pubitemid 27212955)
6. McEwen C., DiTata D., Lingg C., Porini A., Good A., Rankin T., Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis and Reiter's disease. A comparative study. Arthritis and Rheumatism 1971 14 3 291 318 2-s2.0-0015062185
7. Oestreicher J., Walters I., Kikuchi T., Gilleaudeau P., Surette J., Schwertschlag U., Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics Journal 2001 1 4 272 287 (Pubitemid 33756652)
8. Farber E. M., Nall M. L., Watson W., Natural history of psoriasis in 61 twin pairs. Archives of Dermatology 1974 109 2 207 211 2-s2.0-0016029730 10.1001/archderm.109.2.207
9. Friedman S., Blumberg R. S., Braunwald E., Fauci A. S., Kasper D. L., Hauser S. L., Longo D. L., Jameson J. L. VII, Inflammatory bowel disease. Harrison's Principles of Internal Medicine 2001 New York, NY, USA McGraw-Hill 1679 1686
10. Yang H., Plevy S. E., Taylor K., Tyan D., Fischel-Ghodsian N., McElree C., Targan S. R., Rotter J. I., Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut 1999 44 4 519 526 2-s2.0-0032926240 (Pubitemid 29169952)
11. Watts D. A., Satsangi J., The genetic jigsaw of inflammatory bowel disease. Gut 2002 50 3 iii31 iii36 2-s2.0-0036105388 (Pubitemid 34407454)
12. Nair R. P., Henseler T., Jenisch S., Stuart P., Bichakjian C. K., Lenk W., Westphal E., Guo S.-W., Christophers E., Voorhees J. J., Elder J. T., Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Human Molecular Genetics 1997 6 8 1349 1356 2-s2.0-0343410359 10.1093/hmg/6.8.1349 (Pubitemid 27351077)
13. Lee F. I., Bellary S. V., Francis C., Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. The American Journal of Gastroenterology 1990 85 8 962 963 2-s2.0-0025324698 (Pubitemid 20235791)
14. Bernstein C. N., Wajda A., Blanchard J. F., The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005 129 3 827 836 2-s2.0-24144497765 10.1053/j.gastro.2005.06.021 (Pubitemid 41242675)
15. Cohen A. D., Dreiher J., Birkenfeld S., Psoriasis associated with ulcerative colitis and Crohn's disease. Journal of the European Academy of Dermatology and Venereology 2009 23 5 561 565 2-s2.0-63849147057 10.1111/j.1468-3083.2008.03031.x
16. Christophers E., Comorbidities in psoriasis. Clinics in Dermatology 2007 25 6 529 534 (Pubitemid 350087599)
17. Burton P. R., Clayton D. G., Cardon L. R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D. P., McCarthy M. I., Ouwehand W. H., Samani N. J., Todd J. A., Donnelly P., Barrett J. C., Davison D., Easton D., Evans D., Leung H.-T., Marchini J. L., Morris A. P., Spencer C. C. A., Tobin M. D., Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 447 7145 661 678 2-s2.0-34250025139 10.1038/nature05911 (Pubitemid 46889737)
18. Wolf N., Quaranta M., Prescott N. J., Allen M., Smith R., Burden A. D., Worthington J., Griffiths C. E. M., Mathew C. G., Barker J. N., Capon F., Trembath R. C., Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. Journal of Medical Genetics 2008 45 2 114 116 2-s2.0-39149111552 10.1136/jmg.2007.053595 (Pubitemid 351252875)
19. Zeggini E., Weedon M. N., Lindgren C. M., Frayling T. M., Elliott K. S., Lango H., Timpson N. J., Perry J. R. B., Rayner N. W., Freathy R. M., Barrett J. C., Shields B., Morris A. P., Ellard S., Groves C. J., Harries L. W., Marchini J. L., Owen K. R., Knight B., Cardon L. R., Walker M., Hitman G. A., Morris A. D., Doney A. S. F., McCarthy M. I., Hattersley A. T., Bruce I. N., Donovan H., Eyre S., Gilbert P. D., Hider S. L., Hinks A. M., John S. L., Potter C., Silman A. J., Symmons D. P. M., Thomson W., Worthington J., Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007 316 5829 1336 1341. Erratum in Science, vol. 317, pp. 1035-1036, 2007 2-s2.0-34249895023 10.1126/science.1142364 (Pubitemid 46871654)
20. Ogura Y., Bonen D. K., Inohara N., Nicolae D. L., Chen F. F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R. H., Achkar J.-P., Brant S. R., Bayless T. M., Kirschner B. S., Hanauer S. B., Nũez G., Cho J. H., A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 411 6837 603 606 2-s2.0-0035978533 10.1038/35079114 (Pubitemid 32531409)
21. Bonen D. K., Cho J. H., The genetics of inflammatory bowel disease. Gastroenterology 2003 124 2 521 536 2-s2.0-0037308263 10.1053/gast.2003.50045 (Pubitemid 36169267)
22. Lesage S., Zouali H., Cézard J.-P., Colombel J.-F., Belaiche J., Almer S., Tysk C., O'Morain C., Gassull M., Binder V., Finkel Y., Modigliani R., Gower-Rousseau C., Macry J., Merlin F., Chamaillard M., Jannot A.-S., Thomas G., Hugot J.-P., CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. The American Journal of Human Genetics 2002 70 4 845 857 2-s2.0-0036201577 10.1086/339432 (Pubitemid 34259301)
23. Inohara N., Nuñez G., NODS: intracellular proteins involved in inflammation and apoptosis. Nature Reviews Immunology 2003 3 5 371 382 2-s2.0-0038624558 10.1038/nri1086 (Pubitemid 37323197)
24. Watanabe T., Kitani A., Murray P. J., Strober W., NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 2004 5 8 800 808 2-s2.0-4444253690 10.1038/ni1092 (Pubitemid 39172973)
25. Nair R. P., Stuart P., Ogura Y., Inohara N., Chia N. V. C., Young L., Henseler T., Jenisch S., Christophers E., Voorhees J. J., Nuñez G., Elder J. T., Lack of association between NOD2 3020insC frameshift mutation and psoriasis. Journal of Investigative Dermatology 2001 117 6 1671 1672 2-s2.0-0035674155 10.1046/j.0022-202x.2001.01620.x (Pubitemid 34032805)
26. Zhu K., Yin X., Tang X., Zhang F., Yang S., Zhang X., Meta-analysis of NOD2/CARD15 polymorphisms with psoriasis and psoriatic arthritis. Rheumatology International 2012 32 7 1893 1900 2-s2.0-79953047138 10.1007/s00296-011-1813-2
27. Yang S.-K., Loftus E. V. Jr., Sandborn W. J., Epidemiology of inflammatory bowel disease in Asia. Inflammatory Bowel Diseases 2001 7 3 260 270 2-s2.0-0034888589 (Pubitemid 32776521)
28. Cargill M., Schrodi S. J., Chang M., Garcia V. E., Brandon R., Callis K. P., Matsunami N., Ardlie K. G., Civello D., Catanese J. J., Leong D. U., Panko J. M., McAllister L. B., Hansen C. B., Papenfuss J., Prescott S. M., White T. J., Leppert M. F., Krueger G. G., Begovich A. B., A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. The American Journal of Human Genetics 2007 80 2 273 290 2-s2.0-33846608131 10.1086/511051 (Pubitemid 46175676)
29. Smith R. L., Warren R. B., Eyre S., Ho P., Ke X., Young H. S., Griffiths C. E., Worthington J., Polymorphisms in the IL-12 β and IL-23R genes are associated with psoriasis of early onset in a UK cohort. Journal of Investigative Dermatology 2008 128 5 1325 1327 (Pubitemid 351543190)
30. Capon F., di Meglio P., Szaub J., Prescott N. J., Dunster C., Baumber L., Timms K., Gutin A., Abkevic V., Burden A. D., Lanchbury J., Barker J. N., Trembath R. C., Nestle F. O., Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Human Genetics 2007 122 2 201 206 2-s2.0-34547774225 10.1007/s00439-007-0397-0 (Pubitemid 47241785)
31. Nair R. P., Ruether A., Stuart P. E., Jenisch S., Tejasvi T., Hiremagalore R., Schreiber S., Kabelitz D., Lim H. W., Voorhees J. J., Christophers E., Elder J. T., Weichenthal M., Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. Journal of Investigative Dermatology 2008 128 7 1653 1661 2-s2.0-42149140747 10.1038/sj.jid.5701255 (Pubitemid 351847381)
32. Chandran V., Genetics of psoriasis and psoriatic arthritis. The Indian Journal of Dermatology 2010 55 2 151 156 2-s2.0-77952031983 10.4103/0019-5154. 62751
33. Nair R. P., Stuart P. E., Nistor I., Hiremagalore R., Chia N. V. C., Jenisch S., Weichenthal M., Abecasis G. R., Lim H. W., Christophers E., Voorhees J. J., Elder J. T., Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. The American Journal of Human Genetics 2006 78 5 827 851 2-s2.0-33646049742 10.1086/503821
34. Gudjonsson J. E., Karason A., Runarsdottir E. H., Antonsdottir A. A., Hauksson V. B., Jónsson H. H., Gulcher J., Stefansson K., Valdimarsson H., Distinct clinical differences between HLA-Cw0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C- and HLA-B-typed patients. Journal of Investigative Dermatology 2006 126 4 740 745 2-s2.0-33645023965 10.1038/sj.jid.5700118
35. Najarian D. J., Gottlieb A. B., Connections between psoriasis and Crohn's disease. Journal of the American Academy of Dermatology 2003 48 6 805 821 (Pubitemid 36706210)
36. Friberg C., Björck K., Nilsson S., Inerot A., Wahlström J., Samuelsson L., Analysis of chromosome 5q31-32 and psoriasis: confirmation of a susceptibility locus but no association with SNPs within SLC22A4 and SLC22A5. Journal of Investigative Dermatology 2006 126 5 998 1002 2-s2.0-33646149659 10.1038/sj.jid.5700194
37. Li Y., Chang M., Schrodi S. J., Callis-Duffin K. P., Matsunami N., Civello D., Bui N., Catanese J. J., Leppert M. F., Krueger G. G., Begovich A. B., The 5q31 variants associated with psoriasis and Crohn's disease are distinct. Human Molecular Genetics 2008 17 19 2978 2985 2-s2.0-52949124119 10.1093/hmg/ddn196
38. Chang M., Li Y., Yan C., Callis-Duffin K. P., Matsunami N., Garcia V. E., Cargill M., Civello D., Bui N., Catanese J. J., Leppert M. F., Krueger G. G., Begovich A. B., Schrodi S. J., Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes and Immunity 2008 9 2 176 181 2-s2.0-40449113452 10.1038/sj.gene.6364451 (Pubitemid 351351659)
39. Stockinger B., Veldhoen M., Differentiation and function of Th17 T cells. Current Opinion in Immunology 2007 19 3 281 286 2-s2.0-34247555353 10.1016/j.coi.2007.04.005 (Pubitemid 46687011)
40. Steinman L., A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nature Medicine 2007 13 2 139 145 2-s2.0-33846966636 10.1038/nm1551
41. Manel N., Unutmaz D., Littman D. R., The differentiation of human TH-17 cells requires transforming growth factor- β and induction of the nuclear receptor ROR γ t. Nature Immunology 2008 9 6 641 649 2-s2.0-44049104564 10.1038/ni.1610 (Pubitemid 351714729)
42. Ouyang W., Kolls J. K., Zheng Y., The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008 28 4 454 467 2-s2.0-41549135632 10.1016/j.immuni.2008.03.004 (Pubitemid 351471762)
43. Bettelli E., Carrier Y., Gao W., Korn T., Strom T. B., Oukka M., Weiner H. L., Kuchroo V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 7090 235 238 2-s2.0-33646577466 10.1038/nature04753
44. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T. B., Oukka M., Kuchroo V. K., IL-21 initiates an alternative pathway to induce proinflammatory T H17 cells. Nature 2007 448 7152 484 487 2-s2.0-34547232503 10.1038/nature05970 (Pubitemid 47123515)
45. Ye P., Garvey P. B., Zhang P., Nelson S., Bagby G., Summer W. R., Schwarzenberger P., Shellito J. E., Kolls J. K., Interleukin-17 and lung host defense against klebsiella pneumoniae infection. The American Journal of Respiratory Cell and Molecular Biology 2001 25 3 335 340 2-s2.0-0034807936 (Pubitemid 32918915)
46. Infante-Duarte C., Horton H. F., Byrne M. C., Kamradt T., Microbial lipopeptides induce the production of IL-17 in Th cells. Journal of Immunology 2000 165 11 6107 6115 2-s2.0-0034541221
47. Khader S. A., Cooper A. M., IL-23 and IL-17 in tuberculosis. Cytokine 2008 41 2 79 83 2-s2.0-38949133035 10.1016/j.cyto.2007.11.022
48. Huang W., Na L., Fidel P. L., Schwarzenberger P., Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. Journal of Infectious Diseases 2004 190 3 624 631 2-s2.0-3242814586 10.1086/422329 (Pubitemid 38982105)
49. Oppmann B., Lesley R., Blom B., Timans J. C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M.-R., Gorman D., Wagner J., Zurawski S., Liu Y.-J., Abrams J. S., Moore K. W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J. F., Kastelein R. A., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000 13 5 715 725 2-s2.0-0033638507
50. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003 52 1 65 70 2-s2.0-0037216498 10.1136/gut.52.1.65 (Pubitemid 36020767)
51. Fitch E., Harper E., Skorcheva I., Kurtz S. E., Blauvelt A., Pathophysiology of psoriasis: recent advances on IL-23 and TH17 cytokines. Current Rheumatology Reports 2007 9 6 461 467 2-s2.0-37349131221 10.1007/s11926-007-0075-1 (Pubitemid 350305203)
52. Asarch A., Barak O., Loo D. S., Gottlieb A. B., Th17 cells: a new paradigm for cutaneous inflammation. Journal of Dermatological Treatment 2008 19 5 259 266 2-s2.0-51049124043 10.1080/09546630802206686
53. Lee E., Trepicchio W. L., Oestreicher J. L., Pittman D., Wang F., Chamian F., Dhodapkar M., Krueger J. G., Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. Journal of Experimental Medicine 2004 199 1 125 130 2-s2.0-0347285359 10.1084/jem.20030451 (Pubitemid 38076484)
54. Sabat R., Philipp S., Höflich C., Immunopathogenesis of psoriasis. Experimental Dermatology 2007 16 10 779 798 (Pubitemid 47377643)
55. Wolk K., Witte E., Wallace E., Döcke W.-D., Kunz S., Asadullah K., Volk H.-D., Sterry W., Sabat R., IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. The European Journal of Immunology 2006 36 5 1309 1323 2-s2.0-33646552450 10.1002/eji.200535503
56. Toda M., Leung D. Y. M., Molet S., Boguniewicz M., Taha R., Christodoulopoulos P., Fukuda T., Elias J. A., Hamid Q. A., Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. Journal of Allergy and Clinical Immunology 2003 111 4 875 881 2-s2.0-0242670018 10.1067/mai.2003.1414 (Pubitemid 36470263)
57. Sakaguchi S., Powrie F., Emerging challenges in regulatory T cell function and biology. Science 2007 317 5838 627 629 2-s2.0-34547749066 10.1126/science.1142331 (Pubitemid 47229955)
58. +T cells: multiple pathways on the road. Journal of Cellular Physiology 2007 211 3 590 597 2-s2.0-34247643786 10.1002/jcp.21001 (Pubitemid 46683027)
59. + T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 2005 116 1 134 141 2-s2.0-23944443477 10.1111/j.1365-2567.2005.02220.x (Pubitemid 41208360)
60. Liu M.-F., Lin L.-H., Weng C.-T., Weng M.-Y., Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome. Lupus 2008 17 1 34 39 2-s2.0-41749106643 10.1177/0961203307085248 (Pubitemid 351487017)
61. high T cells in patients with new-onset systemic lupus erythematosus. Clinical and Experimental Immunology 2008 153 2 182 187 2-s2.0-47249083906 10.1111/j.1365-2249.2008.03686.x (Pubitemid 351989160)
62. Wei C.-M., Lee J.-H., Wang L.-C., Yang Y.-H., Chang L.-Y., Chiang B.-L., Frequency and phenotypic analysis of CD4+CD25+ regulatory T cells in children with juvenile idiopathic arthritis. Journal of Microbiology, Immunology and Infection 2008 41 1 78 87 2-s2.0-44849104915 (Pubitemid 351792126)
63. Ehrenstein M. R., Evans J. G., Singh A., Moore S., Warnes G., Isenberg D. A., Mauri C., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF α therapy. Journal of Experimental Medicine 2004 200 3 277 285 2-s2.0-3543140687 10.1084/jem.20040165 (Pubitemid 39031247)
64. + T-cells from patients with type 1 diabetes. Diabetes 2005 54 1 92 99 2-s2.0-12144249838 10.2337/diabetes.54.1.92 (Pubitemid 40105099)
65. + regulatory T cells in Crohn's disease. Clinical Immunology 2007 125 3 281 290 2-s2.0-36249014365 10.1016/j.clim.2007.08.003 (Pubitemid 350123608)
66. + regulatory T cells in ulcerative colitis. Inflammatory Bowel Diseases 2007 13 2 191 199 2-s2.0-34249309861 10.1002/ibd.20053 (Pubitemid 46806228)
67. Hirahara K., Liu L., Clark R. A., Yamanaka K.-I., Fuhlbrigge R. C., Kupper T. S., The majority of human peripheral blood CD4+CD25 highFoxp3+ regulatory T cells bear functional skin-homing receptors. Journal of Immunology 2006 177 7 4488 4494 2-s2.0-33749144742 (Pubitemid 44469779)
68. Bovenschen H. J., van Vlijmen-Willems I. M. J. J., van de Kerkhof P. C. M., van Erp P. E. J., Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in psoriasis. Dermatology 2006 213 2 111 117 2-s2.0-33747050644 10.1159/000093849 (Pubitemid 44215194)
69. Bettelli E., Carrier Y., Gao W., Korn T., Strom T. B., Oukka M., Weiner H. L., Kuchroo V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 7090 235 238 2-s2.0-33646577466 10.1038/nature04753
70. Radhakrishnan S., Cabrera R., Schenk E. L., Nava-Parada P., Bell M. P., Van Keulen V. P., Marler R. J., Felts S. J., Pease L. R., Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. Journal of Immunology 2008 181 5 3137 3147 2-s2.0-51549097819
71. Oukka M., Interplay between pathogenic Th17 and regulatory T cells. Annals of the Rheumatic Diseases 2007 66 supplement 3 iii87 iii90 2-s2.0-35649018292 10.1136/ard.2007.078527 (Pubitemid 350032642)